final program.qxd - Parallels Plesk Panel

H R S E Z
60 60 31 24 10
(100%) (100%) (51.6%) (40%) (16%)
RADIOLOGICAL PRESENTATION
XRAY PULMONARY EXTRA PULMONARY
NORMAL 3
MINIMAL 11
LESION
MODERATE 10
LESION 36
FAR ADVANCED
LESION
TOTAL 57 3
MORTALITY DURING TREATMENT
SEX PULMONARY EXTRA PULMONARY
MALE
FEMALE 3
TOTAL 3
To Summarize the above Results
1)The most common set of clinical features included cough,fever, dyspnoea and weight
loss.
2)The microbiological pattern of drug resistance was Isoniazid (n=60), Rifampicin (n=60),
Streptomycin (n=31), Ethambutol (n=24), Pyrazinamide (n=10),
3)The cases were followed up for 2 years.
4)3 cases died during the course of treatment
5)Sputum conversion rate at the end of 3 months was 21 (38.1%), at end of 6 months 37
(67.2%), and at 9 months was 31 (68.8%).
6)Nutrition and compliance was the key to recovery.
POSTERS
Conclusion
1) The Increase in the frequency of infection with M.tuberculosis resistant to anti-TB
drugs is a major threat to its treatment and control program
2) The worsening situation can be effectively tackled by implementing the DOTS
Plus programme with microbiological, psychosocial and nutritional support
systems
3) Regimen of IInd line drugs according to WHO guidelines must be administered
for at least 2 years
4) Proper treatment of associated comorbidities is important in the prevention of
morbidity and mortality associated with MDR-TB.
“ Focusing FIRST on PEOPLE “ 149 w w w . i s h e i d . c o m